Whole lung directed anti-muscarinic therapy improves small airway dysfunction in COPD patients. [PDF]
Usmani OS +4 more
europepmc +1 more source
Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]
Lan Y, Hu D, Huang S, Xu M, He Q.
europepmc +1 more source
Impact of umeclidinium/vilanterol dual bronchodilator therapy on pulmonary function and inflammatory responses in stable COPD patients. [PDF]
Jiang R, Zhan W, Jian X, Li J.
europepmc +1 more source
Lower baseline FEV1 is associated with greater FEV1 improvement after tiotropium add-on in uncontrolled asthma. [PDF]
Shim JS, Ahn KM, Kim MH, Cho YJ.
europepmc +1 more source
Marc Miravitlles,1 David Price,2 Klaus F Rabe,3,7 Hendrik Schmidt,4 Norbert Metzdorf,5 Bartolome Celli6 1Pneumology Department, Hospital Universitari Vall d’Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 2Academic Primary
Rabe KF +5 more
core
Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database. [PDF]
Rui Y +6 more
europepmc +1 more source
Economic evaluation of single-inhaler triple therapy for chronic obstructive pulmonary disease in Thailand. [PDF]
Dilokthornsakul P +3 more
europepmc +1 more source
Economic evaluation of generic inhalational bronchodilators from the Jan-Aushadi scheme versus branded alternatives. [PDF]
James J +3 more
europepmc +1 more source
Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]
Rebordosa C +9 more
europepmc +1 more source

